Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Axsome Thera
(NQ:
AXSM
)
87.63
+2.63 (+3.09%)
Streaming Delayed Price
Updated: 12:59 PM EDT, Jul 31, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Axsome Thera
< Previous
1
2
3
4
5
6
7
8
9
...
14
15
Next >
Does an $11.5 Billion Opportunity Make This Growth Stock a Buy Now?
June 17, 2023
Soaring sales of a new depression treatment could be just the tip of the iceberg for Axsome Therapeutics.
Via
The Motley Fool
This Stock Crushed the Market Last Year. Here's Why It Could Do That Again.
June 16, 2023
This small biotech could become much bigger in just a few years.
Via
The Motley Fool
Stock Market Rally Runs Through Hawkish Fed; Adobe, Lennar, Oracle, UnitedHealth In Focus: Weekly Review
June 16, 2023
Stocks kept powering higher despite, but the Nasdaq is looking extended.
Via
Investor's Business Daily
Is Axsome Therapeutics Stock a Screaming Buy?
June 15, 2023
The biotech could be staring down an enormous commercial opportunity.
Via
The Motley Fool
Why Axsome Therapeutics Stock Is Rising Today
June 14, 2023
Axsome Therapeutics, Inc. (NASDAQ: AXSM) shares are trading higher Wednesday following a recent corporate presentation.
Via
Benzinga
Analyst Expectations for Axsome Therapeutics's Future
June 12, 2023
Via
Benzinga
Axsome Therapeutics's Return On Capital Employed Overview
May 22, 2023
Via
Benzinga
3 Growth Stocks to Buy and Hold
May 13, 2023
These three stocks defied the bear market last year.
Via
The Motley Fool
Expert Ratings for Axsome Therapeutics
May 09, 2023
Via
Benzinga
Axsome Therapeutics Expects Up To $11.5 Billion In Peak Sales, Wallops Analysts' Forecasts
June 14, 2023
The company's biggest products treats depression and could be used in other conditions.
Via
Investor's Business Daily
3 No-Brainer Stocks to Buy in June
June 10, 2023
These biopharma stocks could be big winners.
Via
The Motley Fool
The Top Healthcare Stocks to Buy With $100
June 09, 2023
You don't need a fortune to start investing.
Via
The Motley Fool
Prediction: These 2 Stocks Could Double In the Next Year
May 28, 2023
It would be a continuation of solid recent performances.
Via
The Motley Fool
2 Biotech Stocks That Could Help Set You Up for Life
May 26, 2023
These two promising companies have the potential to beat the market over time.
Via
The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
May 22, 2023
Via
Benzinga
Earnings Outlook For Axsome Therapeutics
May 05, 2023
Via
Benzinga
Axsome Therapeutics Stock: Bear vs. Bull
April 23, 2023
Axsome shares beat the bear market last year.
Via
The Motley Fool
2 Bear Market Defying Stocks to Buy in May
May 22, 2023
These stocks still have plenty of market-beating years ahead.
Via
The Motley Fool
2 Unstoppable Growth Stocks to Buy in 2023 and Beyond
May 20, 2023
Both Axsome Therapeutics and Exelixis have potentially game-changing products in their pipelines.
Via
The Motley Fool
Is a Victory for Its Rivals Bad News for Axsome Therapeutics?
May 17, 2023
The biopharmaceutical company's shares have soared during the past year.
Via
The Motley Fool
Market Rally Diverges; Google Surges On AI News, Inflation Cools, But Breadth Weak: Weekly Review
May 12, 2023
The Nasdaq hit a new 2023 high, but not the S&P 500 or Dow Jones.
Via
Investor's Business Daily
This Analyst Creates Bullish Pitch For Axsome Therapeutics On Increased Outlook For Its Depression Drug
May 11, 2023
Mizuho increased the price target on Axsome Therapeutics Inc (NASDAQ: AXSM) from $84 to $95 with a Buy rating
Via
Benzinga
2 Magnificent Growth Stocks You Can Buy With $150 Right Now
May 10, 2023
You don't have to wait until you're rich to start getting your money to work for you.
Via
The Motley Fool
Axsome's New Drug Is Scoring a Win. Is the Stock a Buy?
May 09, 2023
The biotech's share price more than doubled during last year's bear market.
Via
The Motley Fool
Axsome Therapeutics Clocks Better Than Expected Q1 Sales, Depression Drug Sees Improved Coverage
May 08, 2023
Axsome Therapeutics Inc (NASDAQ: AXSM) reported Q1 revenue of $94.6 million, consisting of net product sales of $28.6 million, license revenue of $65.7 million, and
Via
Benzinga
Axsome Therapeutics (AXSM) Q1 2023 Earnings Call Transcript
May 08, 2023
AXSM earnings call for the period ending March 31, 2023.
Via
The Motley Fool
Axsome Surges As Its Newest Product Shines. But BioXcel Does The Opposite.
May 08, 2023
Axsome shares are nearing a breakout point. But BioXcel crumbled on its report.
Via
Investor's Business Daily
The 3 Most Promising Biotech Innovations in 2023 and the Stocks to Buy
April 28, 2023
Here are three biotech stocks with promising innovations that could provide catalysts for their respective stocks in 2023
Via
InvestorPlace
3 Biotech Stocks to Watch After Johnson & Johnson’s Earnings Beat
April 25, 2023
Discover the latest picks in the biotech industry with our article on 3 biotech stocks to watch after Johnson & Johnson’s earnings beat.
Via
InvestorPlace
If You Invested $5,000 in Axsome Therapeutics 5 Years Ago, Here's How Much You Would Have Now
April 25, 2023
Axsome's new products have blockbuster potential.
Via
The Motley Fool
< Previous
1
2
3
4
5
6
7
8
9
...
14
15
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.